Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Pethe

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Jac-Antimicrobial Resistance|May 11, 2023
Rifaximin potentiates clarithromycin against <i>Mycobacterium abscessus in vitro</i> and in zebrafishBoon Chong Goh, Simon Larsson, Linh Chi Dam, et al.
Microbiology Spectrum|November 20, 2023
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh, et al.
The Journal of Biological Chemistry|January 4, 2024
High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivoPriya Ragunathan, Patcharaporn Sae-Lao, Claire Hamela, et al.
Cell Reports|April 24, 2026
A bioluminescence-based chemical screen identifies a bactericidal naphthalen-1-ylmethanamine scaffold targeting MmpL3 in Mycobacterium abscessusSamsher Singh, Ria Sorayah, Yushu Chen, et al.
Nature Communications|March 28, 2026
Single-bacterial cell insights into mechanisms of ceftriaxone resistance in Neisseria subflavaXin Zhang, Hong Sheng Cheng, Xueliang Zhan, et al.
Infection and Immunity|February 26, 2014
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid compositionMichelle Lay Teng Ang, Siti Zarina Zainul Rahim, Zarina Zainul Rahim Siti, et al.
Cell Chemical Biology|July 28, 2022
Pharmacological perturbation of thiamine metabolism sensitizes Pseudomonas aeruginosa to multiple antibacterial agentsHyung Jun Kim, Yingying Li, Michael Zimmermann, et al.
Nature Communications|December 19, 2018
Targeting the Mycobacterium ulcerans cytochrome bc<sub>1</sub>:aa<sub>3</sub> for the treatment of Buruli ulcerNicole Scherr, Raphael Bieri, Sangeeta S Thomas, et al.
Journal of Medicinal Chemistry|May 30, 2014
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agentSunhee Kang, Ryang Yeo Kim, Min Jung Seo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2021
HflX is a GTPase that controls hypoxia-induced replication arrest in slow-growing mycobacteriaJie Yin Grace Ngan, Swathi Pasunooti, Wilford Tse, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Jac-Antimicrobial Resistance|May 11, 2023
Rifaximin potentiates clarithromycin against <i>Mycobacterium abscessus in vitro</i> and in zebrafishBoon Chong Goh, Simon Larsson, Linh Chi Dam, et al.
Microbiology Spectrum|November 20, 2023
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh, et al.
The Journal of Biological Chemistry|January 4, 2024
High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivoPriya Ragunathan, Patcharaporn Sae-Lao, Claire Hamela, et al.
Cell Reports|April 24, 2026
A bioluminescence-based chemical screen identifies a bactericidal naphthalen-1-ylmethanamine scaffold targeting MmpL3 in Mycobacterium abscessusSamsher Singh, Ria Sorayah, Yushu Chen, et al.
Nature Communications|March 28, 2026
Single-bacterial cell insights into mechanisms of ceftriaxone resistance in Neisseria subflavaXin Zhang, Hong Sheng Cheng, Xueliang Zhan, et al.
Infection and Immunity|February 26, 2014
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid compositionMichelle Lay Teng Ang, Siti Zarina Zainul Rahim, Zarina Zainul Rahim Siti, et al.
Cell Chemical Biology|July 28, 2022
Pharmacological perturbation of thiamine metabolism sensitizes Pseudomonas aeruginosa to multiple antibacterial agentsHyung Jun Kim, Yingying Li, Michael Zimmermann, et al.
Nature Communications|December 19, 2018
Targeting the Mycobacterium ulcerans cytochrome bc<sub>1</sub>:aa<sub>3</sub> for the treatment of Buruli ulcerNicole Scherr, Raphael Bieri, Sangeeta S Thomas, et al.
Journal of Medicinal Chemistry|May 30, 2014
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agentSunhee Kang, Ryang Yeo Kim, Min Jung Seo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2021
HflX is a GTPase that controls hypoxia-induced replication arrest in slow-growing mycobacteriaJie Yin Grace Ngan, Swathi Pasunooti, Wilford Tse, et al.
Pageof 12